AI in Pharmacy: How Artificial Intelligence Is Changing Medication Management

Last updated: October 3, 2026 | By Helathora

Editorial note: This article reflects our independent research and analysis of published studies. Helathora is not a healthcare provider, and this article is for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. AI should support, not replace, the professional judgment of pharmacists, physicians and other qualified healthcare professionals.

2 of 94AI medication-reconciliation studies tackled finding discrepancies; none resolved them

55–98%of drug-interaction alerts overridden in conventional systems

22studies on machine learning for medication-error detection, mostly prescribing errors

~2 millionadverse event reports the FDA receives each year

Managing medication is more complicated than taking a pill on time. Patients may take several medicines, switch treatments, have side effects or conditions that change how drugs work, and pharmacists must weigh all of it. AI in pharmacy aims to help by processing medication data at scale. The evidence so far is mostly early-stage, and several of the most promising uses are still being developed rather than proven.

How We Researched This Article

This is a desk-research article. We did not test any pharmacy software. We:

Prioritized systematic and scoping reviews, regulator publications and peer-reviewed studies over vendor claims.
Checked figures against the original publications and current public sources as of October 2026.
Separated conventional rule-based pharmacy software from AI, since studies often mix the two.

What the Evidence Shows

Application	Source and design	Main finding	Caveat
Medication reconciliation	Scoping review, JMIR 2026: 94 studies	All built medication histories; 2 identified discrepancies; none resolved them; 93 stayed at model development	Maps research; does not measure patient benefit
Error detection	Scoping review (2026): 22 studies	Mostly prescribing errors using structured data; fewer on administration errors using images or video	About 23% tested in simulated settings; authors call for multicenter validation
Interaction alerts	MEDINFO 2021 scoping review: 34 studies	Overrides of drug-interaction alerts ranged from 55% to 98%	Conventional alerts, not AI; shows the problem AI aims to ease
Adherence	Reis et al., Front Digit Health (2025): 7 studies, 3 trials	In randomized trials, AI tools improved adherence by 6.7% to 32.7%	Very small evidence base; varied tools
Pharmacovigilance	FDA program descriptions	FDA is implementing language-processing and machine-learning methods to review safety reports	Describes programs, not outcomes
Governance	FDA and EMA principles, January 2026	Ten principles: human-centric, risk-based, clear context of use, data governance	Non-binding; covers drug development, not pharmacy dispensing

1. Medication Reconciliation: Most Studies Stop at Extraction

Reconciliation compares the medicines a patient takes with those in their record, which matters most when someone is admitted or discharged. AI could extract medications from notes and prescriptions to build a fuller history, then flag inconsistencies for a pharmacist to confirm.

The 2026 scoping review shows how far the field is from that goal. Nearly all work automated the first step, and only one study moved beyond model development.

Number of studies addressing each reconciliation task (out of 94)

Build a medication history: 94

Identify discrepancies: 2

Resolve discrepancies: 0

Source: JMIR scoping review, 2026.

2. Detecting Medication Errors

Errors can occur when prescribing, dispensing or administering. Researchers are testing whether machine learning can spot error patterns, mostly in prescribing. The review of 22 studies found a smaller group using images or video for administration errors. AI shows potential, but nothing here guarantees errors will be prevented.

3. Drug Interactions: Context Is the Promise

Pharmacy software already flags known interactions using rules and databases, and clinicians often override those alerts. AI could add context by combining medication data with labs, history and notes. We did not find randomized evidence that AI-based interaction checking improves outcomes, so rule-based databases and pharmacist review remain essential.

4. Medication Adherence

Patients forget doses, misunderstand instructions or struggle with side effects or cost. A digital system could detect repeated missed doses and alert a pharmacist. Early randomized evidence is encouraging but small, and a human conversation is still needed to understand why a pattern happens.

5. Pharmacovigilance

Pharmacovigilance monitors medicines after approval for safety signals. The FDA receives nearly 2 million adverse event reports a year and is using language processing and machine learning to help review them. A statistical signal does not prove a medicine caused an event, and further evaluation is required (see FDA-Authorized AI Medical Devices 2026: What the List Really Means).

Key takeaway: In pharmacy, AI is best understood as a way to organize information for pharmacists to verify, not to decide what a patient takes.

What Are the Risks?

False alerts. Too many notifications cause alert fatigue, as interaction override rates show.
Missing information. An incomplete medication list cannot be analyzed reliably.
Incorrect predictions. Models can fail on patients unlike those they learned from.
Privacy. Medication records are sensitive and need strong security and governance.
Human oversight. The FDA and EMA principles stress human-centered, risk-based use, though they govern drug development.

Limitations of This Review

Scoping reviews map research activity and do not measure effects on patients.
Most evidence is at the development stage, with little real-world testing.
Some sources describe programs rather than results.
«AI» covers very different tools, so findings do not transfer between applications.

The Bottom Line

AI could help with reconciliation, error detection, adherence and safety surveillance, but evidence is thin and mostly early. The likely future pairs algorithms that surface patterns with pharmacists who verify them, speak with patients and decide. Validation, privacy, transparency and oversight will remain essential.

Frequently Asked Questions

Can AI replace pharmacists?

No. Pharmacists provide clinical judgment, counseling and oversight that algorithms cannot independently replace.

Can AI prevent medication errors?

It may help flag risky patterns, but it cannot guarantee prevention, and most research is still early.

Can AI check drug interactions?

It may support checking when combined with clinical information, but professionals should review important decisions.

Is AI already used in pharmacy?

Yes, in areas such as reconciliation research, safety surveillance and workflow support, but maturity varies widely.

Sources

AI-Based Automation for Medication Reconciliation: Scoping Review. J Med Internet Res 2026;28:e86760.
Machine learning for medication error detection: a scoping review (2026; PMC12934993).
Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review. MEDINFO 2021.
Reis ZSN et al. AI-based tools for patient support to enhance medication adherence. Front Digit Health 2025;7:1523070.
U.S. FDA. Understanding CDER’s Postmarket Safety Surveillance Programs; Improving the Efficiency and Rigor of Pharmacovigilance at FDA.
FDA and EMA. Guiding Principles of Good AI Practice in Drug Development (January 14, 2026).

Important notice: This article is for informational and educational purposes only and is not medical advice, diagnosis, or treatment. Helathora is not a healthcare provider. AI systems discussed here are not a substitute for pharmacists, physicians or other qualified healthcare professionals. Never change, stop or start a medication based solely on an AI-generated recommendation. Consult an appropriately qualified healthcare professional for individual medication decisions.